The marked reduction in RUNXOR and RUNX1 levels in SPMS patients corresponds to a lack of neurogenesis, a characteristic of SPMS due to chronic demyelination and axonal deterioration. This evidence concerns the gene RUNX1 and secondary progressive multiple sclerosis.